In our study, we tested the effects of SMYD2 inhibition on TMPRSS2 expression in HT-29 cells and Caco-2 cells, two human colorectal adenocarcinoma cell lines, and Calu-3 cells, one lung cancer cell line. This evidence concerns the gene TMPRSS2 and colorectal adenocarcinoma.